John L. Waddington

发表

Mice Lacking the α4 Nicotinic Receptor Subunit Fail to Modulate Dopaminergic Neuronal Arbors and Possess Impaired Dopamine Transporter Function

M. K. Horne, R. M. Brown, M. Horne, 2005, Molecular Pharmacology.

The interaction of clozapine with dopamine D1 versus dopamine D2 receptor-mediated function: behavioural indices.

J. Waddington, A. M. Murray, John L. Waddington, 1990, European journal of pharmacology.

𝒟-Amphetamine and Antipsychotic Drug Effects on Latent Inhibition in Mice Lacking Dopamine D2 Receptors

P. Moran, K. Fone, C. O’Tuathaigh, 2013, Neuropsychopharmacology.

Movement disorder and sensorimotor abnormalities in schizophrenia and other psychoses - European consensus on assessment and perspectives

J. Waddington, W. Strik, J. Foucher, 2020, European Neuropsychopharmacology.

Duration of the psychosis prodrome and its relationship to duration of untreated psychosis across all 12 DSM-IV psychotic diagnoses: Evidence for a trans-diagnostic process associated with resilience

A. Kinsella, N. Nkire, John L. Waddington, 2023, European Neuropsychopharmacology.

Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist.

J. Waddington, K. O’boyle, John L. Waddington, 1989, Pharmacology & therapeutics.

Sniffing, rearing and locomotor responses to the D-1 dopamine agonist R-SK&F 38393 and to apomorphine: differential interactions with the selective D-1 and D-2 antagonists SCH 23390 and metoclopramide.

J. Waddington, A. Molloy, John L. Waddington, 1985, European journal of pharmacology.

Schizophrenia‐related endophenotypes in heterozygous neuregulin‐1 ‘knockout’ mice

R. Harvey, D. Lai, C. O’Leary, 2010, The European journal of neuroscience.

Conservation of behavioural topography to dopamine D1-like receptor agonists in mutant mice lacking the D1A receptor implicates a D1-like receptor not coupled to adenylyl cyclase

D. Sibley, J. Drago, A. Kinsella, 1999, Neuroscience.

Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects

Wei Cheng, Jianxin Shi, Elvira Bramon, 2016, Nature Genetics.

Cognitive dysfunction in chronic schizophrenia followed prospectively over 10 years and its longitudinal relationship to the emergence of tardive dyskinesia

J. Waddington, H. Youssef, John L. Waddington, 1996, Psychological Medicine.

Cognitive dysfunction in schizophrenia followed up over 5 years, and its longitudinal relationship to the emergence of tardive dyskinesia

J. Waddington, A. Kinsella, A. Kinsella, 1990, Psychological Medicine.

Essential fatty acids given from conception prevent topographies of motor deficit in a transgenic model of Huntington’s disease

J. Drago, K. Vaddadi, A. Kinsella, 2002, Neuroscience.

Clinical symptomatology and the psychosis risk gene ZNF804A

T. Dinan, F. O’Neill, G. Donohoe, 2010, Schizophrenia Research.

Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects

P. Visscher, J. Sebat, D. Malhotra, 2016, Nature Genetics.